Product Name | Lixisenatide |
---|---|
CAS | 320367-13-3 |
Formula | C215H347N61O65S |
MW | 4,858.49 |
MDL | MFCD13194768 |
Appearance | White to pink powder |
Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
---|---|---|---|---|
1 mg | 3-5 days | ¥1168.00 | Visible after login | |
2 mg | 3-5 days | ¥1866.00 | Visible after login | |
5 mg | 3-5 days | ¥2966.00 | Visible after login |
Product Name | Lixisenatide |
---|---|
CAS | 320367-13-3 |
Formula | C215H347N61O65S |
MW | 4,858.49 |
MDL | MFCD13194768 |
Appearance | White to pink powder |
Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM).It is an injectable diabetes medicine that helps control blood sugar levels.
PMID: 35498599 PMCID: PMC9050383 DOI: 10.1039/c9ra09959j
Low-dose lixisenatide protects against early-onset nephropathy induced in diabetic rats [J].
PMID: 33065146 DOI: 10.1016/j.lfs.2020.118592
PMID: 31336333 DOI: 10.1016/j.intimp.2019.105732